Literature DB >> 9414658

Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension.

I Okayasu1, T Osakabe, M Fujiwara, H Fukuda, M Kato, M Oshimura.   

Abstract

Telomerase activity was examined by telomeric repeat amplification protocol assay in thyroid disease states, including adenomas and carcinomas, and correlated with clinicopathological features. Of a total of 26 papillary carcinomas, 16 cases (61.5%) were positive, with the poorly differentiated subtype being predominant (P < 0.05). A significantly more shortened terminal restriction fragment length (P < 0.05), higher incidence of extrathyroidal extension (P < 0.001), and more elevated Ki-67 labeling indices (P < 0.002) were also found in telomerase-positive than in telomerase-negative papillary carcinomas. Of four follicular carcinomas, 3 cases (75.0%) were positive. Positive telomerase activity in follicular adenomas (9/23 cases, 39.1%) and lymphocytic thyroiditis (12/22 cases, 54.5%) appeared to be mainly caused by infiltrating lymphocytes. However, three cases of atypical adenoma with relatively increased Ki-67 labeling indices were positive, suggesting a possibility of malignant potential. The good correlations with extrathyroidal invasiveness, Ki-67 labeling indices and poor differentiation of papillary carcinomas, established by multivariate analysis, suggest that this parameter might have potential application in the estimation of tumor progression and prognosis, and in clinical management.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9414658      PMCID: PMC5921284          DOI: 10.1111/j.1349-7006.1997.tb00316.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  29 in total

1.  Estimation of the probability of an event as a function of several independent variables.

Authors:  S H Walker; D B Duncan
Journal:  Biometrika       Date:  1967-06       Impact factor: 2.445

2.  Telomerase activity is associated with cell cycle deregulation in human breast cancer.

Authors:  G Landberg; N H Nielsen; P Nilsson; S O Emdin; J Cajander; G Roos
Journal:  Cancer Res       Date:  1997-02-01       Impact factor: 12.701

Review 3.  Telomeres, telomerase, and immortality.

Authors:  M S Rhyu
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

4.  Risk factor analysis in differentiated thyroid cancer.

Authors:  B Cady; C E Sedgwick; W A Meissner; M S Wool; F A Salzman; J Werber
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

5.  Prognosis in thyroid carcinoma.

Authors:  K O Franssila
Journal:  Cancer       Date:  1975-09       Impact factor: 6.860

6.  Telomerase activity is repressed during differentiation of maturation-sensitive but not resistant human tumor cell lines.

Authors:  J Albanell; W Han; B Mellado; R Gunawardane; H I Scher; E Dmitrovsky; M A Moore
Journal:  Cancer Res       Date:  1996-04-01       Impact factor: 12.701

7.  Association of chronic lymphocytic thyroiditis and thyroid papillary carcinoma. A study of surgical cases among Japanese, and white and African Americans.

Authors:  I Okayasu; M Fujiwara; Y Hara; Y Tanaka; N R Rose
Journal:  Cancer       Date:  1995-12-01       Impact factor: 6.860

8.  Significance of lymph node metastasis in differentiated thyroid cancer.

Authors:  J Harwood; O H Clark; J E Dunphy
Journal:  Am J Surg       Date:  1978-07       Impact factor: 2.565

9.  Telomerase activity in normal and malignant hematopoietic cells.

Authors:  D Broccoli; J W Young; T de Lange
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

10.  Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma.

Authors:  I Okayasu; M Saegusa; M Fujiwara; Y Hara; N R Rose
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

View more
  7 in total

1.  Telomerase expression in uveal melanoma.

Authors:  B Heine; S E Coupland; S Kneiff; G Demel; N Bornfeld; M Hummel; H Stein
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

Review 2.  Telomerase and the endocrine system.

Authors:  Furio Pacini; Silvia Cantara; Marco Capezzone; Stefania Marchisotta
Journal:  Nat Rev Endocrinol       Date:  2011-03-29       Impact factor: 43.330

3.  Thyroid carcinomas that express telomerase follow a more aggressive clinical course in children and adolescents.

Authors:  A M Straight; A Patel; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-04       Impact factor: 4.256

Review 4.  Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.

Authors:  M D Ringel
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

5.  Telomeres and thyroid cancer.

Authors:  Marco Capezzone; Stefania Marchisotta; Silvia Cantara; Furio Pacini
Journal:  Curr Genomics       Date:  2009-12       Impact factor: 2.236

6.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas.

Authors:  Paula Soares; Jorge Lima; Ana Preto; Patricia Castro; João Vinagre; Ricardo Celestino; Joana P Couto; Hugo Prazeres; Catarina Eloy; Valdemar Máximo; M Sobrinho-Simões
Journal:  Curr Genomics       Date:  2011-12       Impact factor: 2.236

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.